Company · CIK 1661998
Q32 Bio Inc.
| CIK | 1661998 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | MA |
| Listed | QTTB (Nasdaq) |
| First annual or quarterly report | 2018-05-14 |
Offerings
8 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-297538 | 2026-07-17 | 2026-07-28 | 2 | |
| 333-297027 | 2026-06-25 | 2026-07-15 | 4 | |
| 333-286491 | 2025-04-11 | 2026-04-24 | 5 | |
| 333-278829 | 2024-04-19 | 2025-04-16 | 3 | |
| 333-270414 | 2023-03-09 | 2023-03-17 | 2 | |
| 333-237131 | 2020-03-12 | 2021-04-08 | 4 | |
| 333-230664 | 2019-04-01 | 2019-04-10 | 4 | |
| 333-223409 | 2018-03-02 | 2018-03-29 | 6 |
Filings
32| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-07-28 | EFFECTDeclared effective | 333-297538 | 9999999995-26-002481 |
| 2026-07-17 | S-3Shelf registered | 333-297538 | 0001193125-26-307835 |
| 2026-07-15 | 424B5Shelf takedown | 333-297027 | 0001193125-26-304946 |
| 2026-07-13 | EFFECTDeclared effective | 333-297027 | 9999999995-26-002273 |
| 2026-07-13 | 424B5Shelf takedown | 333-297027 | 0001193125-26-302100 |
| 2026-06-25 | S-3Shelf registered | 333-297027 | 0001193125-26-282783 |
| 2026-04-24 | 424B5Shelf takedown | 333-286491 | 0001193125-26-177170 |
| 2026-03-27 | 424B5Shelf takedown | 333-286491 | 0001193125-26-129424 |
| 2026-02-17 | 424B5Shelf takedown | 333-286491 | 0001193125-26-054660 |
| 2025-04-21 | EFFECTDeclared effective | 333-286491 | 9999999995-25-001168 |
| 2025-04-16 | EFFECTDeclared effective | 333-278829 | 9999999995-25-001127 |
| 2025-04-11 | S-3Shelf registered | 333-286491 | 0001193125-25-079136 |
| 2024-04-29 | EFFECTDeclared effective | 333-278829 | 9999999995-24-001193 |
| 2024-04-19 | S-1Registration filed | 333-278829 | 0001193125-24-102858 |
| 2024-02-14 | EFFECTDeclared effective | 333-276093 | 9999999995-24-000458 |
| 2023-03-17 | EFFECTDeclared effective | 333-270414 | 9999999995-23-000606 |
| 2023-03-09 | S-3Shelf registered | 333-270414 | 0001193125-23-066165 |
| 2021-04-08 | 424B5Shelf takedown | 333-237131 | 0001193125-21-109628 |
| 2021-04-07 | 424B5Shelf takedown | 333-237131 | 0001193125-21-107799 |
| 2021-03-12 | EFFECTDeclared effective | 333-237131 | 9999999995-21-000926 |
| 2020-03-12 | S-3ASRShelf registered | 333-237131 | 0001193125-20-071690 |
| 2019-04-10 | 424B5Shelf takedown | 333-230664 | 0001193125-19-102942 |
| 2019-04-09 | EFFECTDeclared effective | 333-230664 | 9999999995-19-000651 |
| 2019-04-08 | 424B5Shelf takedown | 333-230664 | 0001193125-19-100794 |
| 2019-04-01 | S-3Shelf registered | 333-230664 | 0001193125-19-094628 |
| 2018-03-29 | 424B4Final prospectus | 333-223409 | 0001193125-18-102134 |
| 2018-03-27 | EFFECTDeclared effective | 333-223409 | 9999999995-18-000685 |
| 2018-03-27 | S-1/AAmendment | 333-223409 | 0001193125-18-096873 |
| 2018-03-23 | S-1/AAmendment | 333-223409 | 0001193125-18-092800 |
| 2018-03-19 | S-1/AAmendment | 333-223409 | 0001193125-18-086586 |
| 2018-03-02 | S-1Registration filed | 333-223409 | 0001193125-18-068882 |
| 2017-12-22 | DRSDraft made public | 377-01860 | 0000950123-17-011525 |